Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study

W. Jongbloed, M.I. Kester, W.M. van der Flier, R. Veerhuis, P. Scheltens, M.A. Blankenstein, C.E. Teunissen

    Research output: Contribution to JournalArticleAcademicpeer-review

    Abstract

    Background: Multiplex assays such as xMAP have been proposed for the assessment of Alzheimer's disease (AD) biomarkers amyloid β 42 (Aβ
    Original languageEnglish
    Pages (from-to)276-283
    JournalAlzheimers & Dementia
    Volume9
    Issue number3
    DOIs
    Publication statusPublished - 2013

    Fingerprint

    Dive into the research topics of 'Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study'. Together they form a unique fingerprint.

    Cite this